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The commercial determinants of health
WHO Director-General Margaret Chan has noted that 
“eﬀ orts to prevent non-communicable diseases go 
against the business interests of powerful economic 
operators”.1 Selling processed food and drink, alcohol, 
and tobacco is big business and demand is booming, 
especially in low-income and middle-income countries. 
There has always been critical public health analysis 
of the power of the corporate sector— especially in the 
ﬁ eld of tobacco—and attention has turned to other 
areas in recent years, including work on unhealthy 
commodities,2 industrial epidemics,3 proﬁ t-driven 
diseases,4 and corporate practices harmful to health.5 
The focus on lifestyle choices has also been extensively 
critiqued, especially in relation to marketing to children.6
These domains of study share signiﬁ cant overlaps, yet 
researchers are often divided by discipline, approach, and 
health topic. We believe there is value in conceptually 
uniting this work under the banner of the commercial 
determinants of health: a synergistic, multidisciplinary 
ﬁ eld that addresses the drivers and channels through 
which corporations propagate the non-communicable 
diseases pandemic.
Previous deﬁ nitions of commercial determinants of 
health have stressed the fundamental conﬂ ict between 
imperative shareholder value maximisation and 
population health—for example, West and Marteau’s 
“factors that inﬂ uence health which stem from the proﬁ t 
motive”.7 This broad deﬁ nition does not capture the 
inherent complexity of commercial determinants, and the 
proﬁ t motive also applies to companies that sell health-
promoting products such as fruit and vegetables. Other 
deﬁ nitions have stressed the centrality of consumption, 
but there are other channels through which companies 
inﬂ uence governments, society, and consumers.
We deﬁ ne the commercial determinants of health as 
“strategies and approaches used by the private sector 
to promote products and choices that are detrimental 
to health”. This single concept unites a number of 
others: at the micro level, these include consumer and 
health behaviour, individualisation, and choice; at the 
macro level, the global risk society, the global consumer 
society, and the political economy of globalisation.
Three inter-related factors have changed the global 
business and consumption landscapes while boosting 
the power of large companies: rising demand, increasing 
market coverage, and the continued internationalisation 
of trade and investment (ﬁ gure). Empirical evidence can 
be found in the escalating number of international trade 
deals, inexorable market penetration in low-income and 
middle-income countries, and metrics such as the MSCI 
Consumer Staples Index (covering tobacco, food, and 
drinks), which has grown by 200% in low-income and 
middle-income countries over the last decade. 
Corporate inﬂ uence is exerted through four channels: 
marketing, which enhances the desirability and 
acceptability of unhealthy commodities; lobbying, 
which can impede policy barriers such as plain 
packaging and minimum drinking ages; corporate social 
responsibility strategies, which can deﬂ ect attention 
and whitewash tarnished reputations; and extensive 
supply chains, which amplify company inﬂ uence around 
the globe. These channels boost corporate reach and 
magnify the health impact of commercial enterprise. 
The breadth and depth of corporate inﬂ uence is 
expanded as more people are reached with ever more 
consumption choices.
The absence of publicly available data on corporate 
practices is a major issue and concerted eﬀ orts to quantify 
these channels are an important task  for the public health 
community. Select data are available; for instance Coca-
Cola, PepsiCo, and the American Beverage Association 
spent a total of US$114 million on lobbying at the federal 
level between 2009 and 2015;8 45% of people living in 
countries that have ratiﬁ ed the Framework Convention 
on Tobacco Control report continued exposure to tobacco 
marketing;9 and companies openly speak about using so-
called corporate citizenship to buﬀ  their public image.10
Health outcomes are determined by the inﬂ uence of 
corporate activities on the social environment in which 
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people live and work: namely the availability, cultural 
desirability, and prices of unhealthy products. The 
environment shapes the so-called lifeworlds, lifestyles, 
and choices of individual consumers—ultimately 
determining health outcomes. 
The commercial determinants of health framework 
presented here is not intended to be exhaustive, but to 
spark the discussion that ends with the establishment of 
the commercial determinants of health as a stand-alone 
ﬁ eld of study, reﬂ ected with courses and departments at 
universities and public health institutions worldwide. 
The rise of non-communicable diseases is a 
manifestation of a global economic system that 
currently prioritises wealth creation over health creation. 
Many key problems and solutions lie outside the health 
sector, especially in the domains of international ﬁ nance, 
trade, and investment policies. There is no quick ﬁ x for 
misaligned incentives, uncorrected externalities, and 
widespread cognitive dissonance. The paradoxes of the 
21st century demand deep interdisciplinary collaboration 
and the concept of commercial determinants of health 
provides this distinct conceptual space for uniting 
diﬀ erent researchers and policy makers in pursuit of a 
common goal. Advancing the systematic consideration 
of the private sector is vital to promoting health in an 
increasingly globalised and consumer-oriented world. 
In the vernacular of our corporate colleagues, our 
current piecemeal eﬀ orts to combat the commercial 
drivers of non-communicable diseases is leaving value 
on the table. It is time to systematise our eﬀ orts to 
confront commercial drivers of disease.
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